Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia

References

• WHO. [webpage on the internet]Depression2012 [updated on October 2015]. Available from: http://www.who.int/mediacentre/factsheets/fs369/en/Accessed January 10, 2016
   Google Scholar
• WhitefordHADegenhardtLRehmJGlobal burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010Lancet201338299041575158623993280
   PubMed Web of Science ®Google Scholar
• HuTWHeYZhangMChenNEconomic costs of depression in ChinaSoc Psychiatry Psychiatr Epidemiol200742211011617235441
   PubMed Web of Science ®Google Scholar
• SadoMYamauchiKKawakamiNCost of depression among adults in Japan in 2005Psychiatry Clin Neurosci201165544245021851453
   PubMed Web of Science ®Google Scholar
• ChangSMHongJPChoMJEconomic burden of depression in South KoreaSoc Psychiatry Psychiatr Epidemiol201247568368921526429
   PubMed Web of Science ®Google Scholar
• KesslerRCBerglundPDemlerONational Comorbidity Survey ReplicationThe epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R)JAMA2003289233095310512813115
   PubMed Web of Science ®Google Scholar
• RapaportMHClaryCFayyadREndicottJQuality-of-life impairment in depressive and anxiety disordersAm J Psychiatry200516261171117815930066
   PubMed Web of Science ®Google Scholar
• ZimmermanMMcGlincheyJBPosternakMAFriedmanMAttiullahNBoerescuDHow should remission from depression be defined? The depressed patient’s perspectiveAm J Psychiatry2006163114815016390903
   PubMed Web of Science ®Google Scholar
• McKnightPEKashdanTBThe importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment researchClin Psychol Rev200929324325919269076
   PubMed Web of Science ®Google Scholar
• SolomonDALeonACEndicottJPsychosocial impairment and recurrence of major depressionCompr Psychiatry200445642343015526252
   PubMed Web of Science ®Google Scholar
• TrivediMHDunnerDLKornsteinSGPsychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended releaseJ Affect Disord2010126342042920510459
   PubMed Web of Science ®Google Scholar
• VittenglJRClarkLAJarrettRBDeterioration in psychosocial functioning predicts relapse/recurrence after cognitive therapy for depressionJ Affect Disord20091121–313514318539337
   PubMed Web of Science ®Google Scholar
• KirmayerLRobbinsJDworkindMYaffeMJSomatization and the recognition of depression and anxiety in primary careAm J Psychiatry199315057347418480818
   PubMed Web of Science ®Google Scholar
• CorrubleEGuelfiJDPain complaints in depressed inpatientsPsychopathology200033630730911060514
   PubMed Web of Science ®Google Scholar
• BairMJRobinsonRLKatonWKroenkeKDepression and pain comorbidity: a literature reviewArch Intern Med2003163202433244514609780
   PubMed Web of Science ®Google Scholar
• BairMJRobinsonRLEckertGJStangPECroghanTWKroenkeKImpact of pain on depression treatment response in primary carePsychosom Med2004661172214747633
   PubMed Web of Science ®Google Scholar
• MunozRAMcBrideMEBrnabicAJMajor depressive disorder in Latin America: the relationship between depression severity, painful somatic symptoms, and quality of lifeJ Affect Disord2005861939815820276
   PubMed Web of Science ®Google Scholar
• VaccarinoALSillsTLEvansKRKalaliAHMultiple pain complaints in patients with major depressive disorderPsychosom Med200971215916219073755
   PubMed Web of Science ®Google Scholar
• ArnowBAHunkelerEMBlaseyCMComorbid depression, chronic pain, and disability in primary carePsychosom Med200668226226816554392
   PubMed Web of Science ®Google Scholar
• DemyttenaereKReedCQuailDPresence and predictors of pain in depression: results from the FINDER studyJ Affect Disord20101251–3536020188422
   PubMed Web of Science ®Google Scholar
• BymasterFPLeeTCKnadlerMPDetkeMJIyengarSThe dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depressionCurr Pharm Des200511121475149315892657
   PubMed Web of Science ®Google Scholar
• RobinsonMJSheehanDGaynorPJRelationship between major depressive disorder and associated painful physical symptoms: analysis of data from two pooled placebo-controlled, randomized studies of duloxetineInt Clin Psychopharmacol201328633033823873291
   PubMed Web of Science ®Google Scholar
• BrechtSCourtecuisseCDebieuvreCEfficacy and safety of duloxetine 60 mg once daily in the treatment of pain in patients with major depressive disorder and at least moderate pain of unknown etiology: a randomized controlled trialJ Clin Psychiatry200768111707171618052564
   PubMed Web of Science ®Google Scholar
• FavaMMallinckrodtCHDetkeMJWatkinJGWohlreichMMThe effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?J Clin Psychiatry200465452153015119915
   PubMed Web of Science ®Google Scholar
• PapakostasGIThaseMEFavaMNelsonJCSheltonRCAre antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agentsBiological Psychiatry200762111217122717588546
   PubMed Web of Science ®Google Scholar
• ThaseMEPritchettYLOssannaMJSwindleRWXuJDetkeMJEfficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorderJ Clin Psychopharmacol200727667267618004135
   PubMed Web of Science ®Google Scholar
• ThaseMEEntsuahARRudolphRLRemission rates during treatment with venlafaxine or selective serotonin reuptake inhibitorsBr J Psychiatry200117823424111230034
   PubMed Web of Science ®Google Scholar
• SheehanDVThe Anxiety DiseaseNew York, NYScribner’s1983
   Google Scholar
• BechPSocial functioning: should it become an endpoint in trials of antidepressants?CNS Drugs200519431332415813645
   PubMed Web of Science ®Google Scholar
• WHOThe ICD-10 Classification of Mental and Behavioural Disorders Clinical Descriptions and Diagnostic GuidelinesGenevaWorld Health Organization1992
   Google Scholar
• APADiagnostic and Statistical Manual of Mental Disorders4th edWashington, DCAmerican Psychiatric Publishing2000 Text revision
   Google Scholar
• GuyWECDEU Assessment Manual for Psychopharmacology (Revised)Bethesda, MDU.S. Department of Health, Education and Welfare1976
   Google Scholar
• McGahueyCAGelenbergAJLaukesCAThe Arizona Sexual Experience Scale (ASEX): reliability and validityJ Sex Marital Ther2000261254010693114
   PubMed Web of Science ®Google Scholar
• DuenasHBrnabicAJMLeeATreatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational periodInt J Psychiatry Clin Pract201115424225422121997
   PubMed Web of Science ®Google Scholar
• DuenasHLeeABrnabicAJMFrequency of treatment-emergent sexual dysfunction and treatment effectiveness during SSRI or duloxetine therapy: 8-week data from a 6-month observational studyInt J Psychiatry Clin Pract2011152809022121855
   PubMed Web of Science ®Google Scholar
• HongJNovickDMontgomeryWReal-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaAsia Pac Psychiatry Epub 2015 Mar 24
   Web of Science ®Google Scholar
• RushAJTrivediMHIbrahimHMThe 16-item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depressionBiol Psychiatry200354557358312946886
   PubMed Web of Science ®Google Scholar
• KroenkeKSpitzerRLWilliamsJBPhysical symptoms in primary care. Predictors of psychiatric disorders and functional impairmentArch Fam Med1994397747797987511
   PubMedGoogle Scholar
• CohenJStatistical Power Analysis for the Behavioral Sciences2nd edHillsdale, NJLawrence Eribaum Associates1988
   Google Scholar
• ManciniMSheehanDVDemyttenaereKEvaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale: pooled analysis of data from six randomized, double-blind, placebo-controlled clinical studiesInt Clin Psychopharmacol201227629830922954893
   PubMed Web of Science ®Google Scholar
• OakesTMMyersALMarangellLBAssessment of depressive symptoms and functional outcomes in patients with major depressive disorder treated with duloxetine versus placebo: primary outcomes from two trials conducted under the same protocolHum Psychopharmacol2012271475622241678
   PubMed Web of Science ®Google Scholar
• SambunarisAGommollCChenCGreenbergWMEfficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsInt Clin Psychopharmacol201429419720524667487
   PubMed Web of Science ®Google Scholar
• DunlopBWReddySYangLLubaczewskiSFochtKGuico-PabiaCJSymptomatic and functional improvement in employed depressed patients: a double-blind clinical trial of desvenlafaxine versus placeboJ Clin Psychopharmacol201131556957621869698
   PubMed Web of Science ®Google Scholar
• LamRWEndicottJHsuMAFayyadRGuico-PabiaCBoucherMPredictors of functional improvement in employed adults with major depressive disorder treated with desvenlafaxineInt Clin Psychopharmacol201429523925124583567
   PubMed Web of Science ®Google Scholar
• KocsisJHSchatzbergARushAJPsychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placeboArch Gen Psychiatry200259872372812150648
   PubMed Web of Science ®Google Scholar
• SoaresCNKornsteinSGThaseMEJiangQGuico-PabiaCJAssessing the efficacy of desvenlafaxine for improving functioning and well-being outcome measures in patients with major depressive disorder: a pooled analysis of 9 double-blind, placebo-controlled, 8-week clinical trialsJ Clin Psychiatry200970101365137119906341
   PubMed Web of Science ®Google Scholar
• HamiltonMA rating scale for depressionJ Neurol Neurosurg Psychiatry196023566214399272
   PubMed Web of Science ®Google Scholar
• SheehanDVChokkaPRGrangerREWaltonRJRaskinJSagmanDClinical and functional outcomes in patients with major depressive disorder and painful physical symptoms switched to treatment with duloxetineHum Psychopharmacol201126324225121681815
   PubMed Web of Science ®Google Scholar
• FukuchiTKanemotoKDifferential effects of milnacipran and fluvoxamine, especially in patients with severe depression and agitated depression: a case-control studyInt Clin Psychopharmacol2002172535811890186
   PubMed Web of Science ®Google Scholar
• AngstJSexual problems in healthy and depressed personsInt Clin Psychopharmacol199813suppl 6S1S49728667
   PubMed Web of Science ®Google Scholar
• BonierbaleMLanconCTignolJThe ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in FranceCurr Med Res Opin200319211412412740155
   PubMed Web of Science ®Google Scholar